We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

002493:SZSERongsheng Petrochemical Co., Ltd. Analysis

Data as of 2026-06-13 - not real-time

CN¥11.34

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Rongsheng Petrochemical trades at CNY 11.34, well below its DCF‑derived fair value of CNY 22.75, implying roughly a 13% upside. Valuation metrics such as a trailing P/E of 35.4 and a forward P/E of 16.9 suggest the market is pricing in significant earnings pressure, yet the forward multiple hints at earnings recovery. The stock exhibits a low computed beta of 0.16 but a high 30‑day volatility of 44.7%, reflecting sharp price swings despite limited market correlation. Fundamentally, the company faces a steep revenue decline of 19% YoY, thin profit margins (1.0% net), a massive debt‑to‑equity ratio of 216, and negative free cash flow, raising concerns about cash sustainability despite a modest dividend yield of 0.88% and a payout ratio of 31%.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price marginally below the 20‑day SMA and near the 200‑day SMA, indicating a neutral technical stance
  • Bearish MACD histogram and RSI around 45 suggest limited upside momentum
  • High short‑term volatility may produce price swings around the support level of 10.5

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • DCF fair value indicates ~13% upside, supporting a mean‑reversion thesis
  • Forward earnings estimate (EPS 0.67) cuts the P/E to ~17, aligning with sector averages
  • Increasing volume trend points to growing investor interest

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Strategic exposure to new‑energy and polymer markets could drive top‑line recovery
  • Undervalued relative to intrinsic value and potential for debt restructuring
  • Long‑run dividend yield, though modest, provides a cushion if cash conversion improves

Key Metrics & Analysis

Financial Health

Revenue Growth-19.10%
Profit Margin1.04%
P/E Ratio35.4
ROE7.10%
ROA2.04%
Debt/Equity216.53
P/B Ratio2.3
Op. Cash FlowCN¥46.0B
Free Cash FlowCN¥-25592322048

Technical Analysis

TrendNeutral
RSI44.8
SupportCN¥10.50
ResistanceCN¥13.02
MA 20CN¥11.47
MA 50CN¥12.15
MA 200CN¥11.43
MACDBearish
VolumeIncreasing
Fear & Greed Index89.86

Valuation

Fair ValueCN¥22.75
Target PriceCN¥12.81
Upside/Downside12.96%
GradeUndervalued
TypeBlend
Dividend Yield0.88%

Risk Assessment

Beta0.16
Volatility44.73%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.